Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy

Y. S. Hong, S. H. Korman, J. Lee, Pushpankur Ghoshal, Q. Wu, V. Barash, S. Kang, S. Oh, M. Kwon, A. Gutman, A. Rachmel, M. S. Patel

Research output: Contribution to journalShort survey

23 Scopus citations


Dihydrolipoamide dehydrogenase (E3) deficiency with a clinical phenotype and genotype (Gly194Cys homozygous), previously identified only in Ashkenazi Jewish patients, was diagnosed in two Palestinian Arab siblings and two unrelated Ashkenazi Jewish patients. While three of the four patients died in childhood without specific treatment, the surviving patient at age 18 years may have benefited from long-term daily supplementation with a cocktail of riboflavin, biotin, coenzyme Q and carnitine.

Original languageEnglish (US)
Pages (from-to)816-818
Number of pages3
JournalJournal of Inherited Metabolic Disease
Issue number8
Publication statusPublished - Dec 1 2003
Externally publishedYes


ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this